Vimedimex Medi-Pharma JSC (HOSE:VMD)
Vietnam · Delayed Price · Currency is VND 15,000
+50 (0.33%)
At close: Apr 29, 2026
Vimedimex Medi-Pharma JSC Revenue
In the year 2025, Vimedimex Medi-Pharma JSC had annual revenue of 812.98B VND, down -34.95%. Vimedimex Medi-Pharma JSC had revenue of 276.21B in the half year ending December 31, 2025, a decrease of -79.48%.
Revenue
812.98B
Revenue Growth
-34.95%
P/S Ratio
0.28
Revenue / Employee
26.23B
Employees
31
Market Cap
231.60B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 812.98B | -436.89B | -34.95% |
| Dec 31, 2024 | 1.25T | -2,286.78B | -64.66% |
| Dec 31, 2023 | 3.54T | -3,536.85B | -50.00% |
| Jan 1, 2023 | 7.07T | -5,245.25B | -42.58% |
| Dec 31, 2021 | 12.32T | -5,843.44B | -32.17% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jan 1, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Vidipha Central Pharmaceutical JSC | 971.25B |
| Ben Tre Pharmaceutical JSC | 860.31B |
| Pharmedic Pharmaceutical Medicinal JSC | 546.57B |
| Central Pharmaceutical Joint Stock Company No3 | 481.09B |
| Mediplantex National Pharmaceutical JSC | 366.83B |
| Lamdong Pharmaceutical JSC | 242.87B |
| SPM Corporation | 217.45B |
| American Vietnamese Biotech Incorporation | 154.07B |